年龄对接受免疫抑制治疗的获得性再生障碍性贫血患者的影响:青少年与年轻成人同儿童及年长成人的比较
该回顾性研究在圣路易医院比较了29例儿童(<15岁)、32例青少年与年轻成人(AYA,15-25岁)和23例年长成人(>25岁)接受一线免疫抑制治疗的获得性再生障碍性贫血结局。成人应答累积发生率低于AYA,而儿童与AYA无差异;AYA的应答率和生存与儿童相似,但成人总生存劣于AYA。
要点
- 成人应答累积发生率低于AYA(SHR=0·38,P=0·008),儿童与AYA无差异(SHR=0·84,P=0·56)。
- 6个月部分应答率:儿童44·8%,AYA 62·5%,成人21·7%。
- 5年总生存率86·5%;成人总生存劣于AYA(HR=4·98,P=0·049),儿童与AYA无显著差异(HR=1·51,P=0·66)。
核心结论
- 年龄是接受免疫抑制治疗的获得性再生障碍性贫血患者的预后因素。
- AYA患者的应答率和生存与儿童相似,而成人的应答累积发生率和总生存均劣于AYA。
研究设计与样本
- 回顾性研究,在圣路易医院比较29例儿童(<15岁)、32例AYA(15-25岁)和23例年长成人(>25岁)接受一线免疫抑制治疗的获得性再生障碍性贫血患者。
主要发现
- 成人应答累积发生率低于AYA(SHR=0·38,95%CI 0·96-1·00,P=0·008),儿童与AYA无差异(SHR=0·84,95%CI 0·96-1·00,P=0·56)。
- 6个月部分应答累积发生率:儿童44·8%,AYA 62·5%,成人21·7%。
- 5年无失败生存率为48·4%,不受年龄影响;5年复发率为20·7%。
- 中位随访5·4年,5年总生存率为86·5%;儿童与AYA总生存无显著差异(HR=1·51,95%CI 0·25-9·02,P=0·66),成人总生存劣于AYA(HR=4·98,95%CI 1·00-24·73,P=0·049)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The incidence of acquired aplastic anaemia (AA) peaks in adolescents and young adults (AYA). Although age has been associated with response after immunosuppressive therapy (IST), few data exist about the specific outcome of AYA. We retrospectively compared the outcome of 29 children (aged <15 years), 32 AYA (15-25 years) and 23 adults (>25 years) with AA treated front-line with IST in Saint-Louis Hospital. The cumulative incidence of response was lower in adults compared with AYA (subdistribution hazard ratio [SHR] = 0·38, 95% confidence interval [CI] [0·96-1·00], P = 0·008), but no difference was observed between children and AYA (SHR = 0·84, 95% CI [0·96-1·00], P = 0·56), with a 6 months cumulative incidence of partial response of 44·8% in children, 62·5% in AYA and 21·7% in adults. The 5-year failure-free survival was 48·4%, without impact of age, with a 5-year relapse rate of 20·7%. With a median follow-up of 5·4 years, the 5-year overall survival was 86·5%, without significant difference between children and AYA overall survival (hazard ratio [HR] 1·51, 95% CI [0·25-9·02], P = 0·66), while adults displayed poorer survival than AYA (HR 4·98, 95% CI [1·00-24·73], P = 0·049). This study confirms that age is a prognostic factor in AA patients treated with IST. However, AYA patients have a similar outcome to children in terms of response rate and survival.
引用
- Cabannes-Hamy A, Boissel N, Peffault De Latour R, et al. The effect of age in patients with acquired aplastic anaemia treated with immunosuppressive therapy: comparison of Adolescents and Young Adults with children and older adults. Br J Haematol. 2018. PMID: 30407615. doi:10.1111/bjh.15650
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。